AZN 250103 67.00P (AZN250103P67000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

AZN250103P67000

Watchlist

0.76
-0.39-33.91%

15min DelayClose Jan 3 16:00 ET

1.15High0.61Low

Intraday

5D
Daily

News

AstraZeneca PLC Stock Flat Friday
Dow Jones12:01 ET
AstraZeneca (AZN.US) has initiated a Phase III clinical trial for the PD-1/TIGIT dual antibody.
AstraZeneca (AZN.US) has launched Phase III clinical trials for its PD-1/TIGIT dual antibody.
Zhitong FinanceJan 3 08:19 ET
AstraZeneca Call Volume Above Normal and Directionally Bullish
TipRanksJan 2 14:25 ET
Unusual Options Activity: NCLH, AZN and Others Attract Market Bets, NCLH V/OI Ratio Reaches 55.6
Moomoo NewsJan 2 13:30 ET
AstraZeneca Announces Share Capital and Voting Rights Update
TipRanksJan 2 10:02 ET
AstraZeneca (AZN.US) "Osimertinib" has been approved for a new indication in China.
On January 2nd, the National Medical Products Administration website showed that AstraZeneca (AZN.US)'s application for the new indication of Osimertinib has officially been approved.
Zhitong FinanceJan 2 08:16 ET

Comments

10xStockPicks

Dec 29, 2024 17:56

Roaring Kitty New Years Eve Party, New Investment Idea For 2025

It is rumored Keith Gill will make new investments in 2025 potentially in the health care sector, based on the new Trump administration & RFK looking out for the health of Americans. Rumor is Keith is attending a New Years Eve party with a friend who's father take a statin alternative drug called NEXLIZET made by $Esperion Therapeutics (ESPR.US)$
This information comes from a friend of CNBC Jim Cramer who is also statin intolerant an...

Meltyy

Dec 17, 2024 01:56

📌 1 PDUFA this weekand 6 more upcoming this month! 🚀

🔔 This Week’s PDUFA:
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 15, 2024 15:56

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...

Phil Dunn

Dec 14, 2024 10:48

Weekly Trading Report (2nd Week Dec)

A quick update of my trading activities in this week (9 to 13 Dec 2024).
New Positions
$Symbotic (SYM.US)$ , $IonQ Inc (IONQ.US)$ , $Alphabet-A (GOOGL.US)$ , $PepsiCo (PEP.US)$ , $Futu Holdings Ltd (FUTU.US)$
Sold out Positions
$Hershey (HSY.US)$ , $UnitedHealth (UNH.US)$ , $Taiwan Semiconductor (TSM.US)$
Increased / Decreased Positions
None
Remarks
- I sold out $Hershey (HSY.US)$ after buyout news came out. I took decent profit from this rumour.
- Just few days after I bought $UnitedHealth (UNH.US)$ , I sold ...

2024 recap: Relive your key investment moments